Travere Therapeutics, Inc. (TVTX) — SC 13G/A Filings
All SC 13G/A filings from Travere Therapeutics, Inc.. Browse 12 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (12)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 8, 2024
- SC 13G/A Filing — Nov 4, 2024
- SC 13G/A Filing — Oct 18, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 13, 2024
-
Janus Henderson Amends Travere Therapeutics Stake as of 12/31/23
— Feb 12, 2024 Risk: low
Janus Henderson Group plc, a major investment advisor, filed an amended Schedule 13G/A on February 12, 2024, disclosing its ownership in Travere Therapeutics, I -
Adage Capital Partners Amends Travere Therapeutics Stake
— Feb 7, 2024
Adage Capital Partners, L.P. filed an amended SC 13G/A on February 7, 2024, indicating a change in their ownership of Travere Therapeutics, Inc. common stock as -
State Street Corp Amends Travere Therapeutics Stake Filing
— Jan 25, 2024
State Street Corp, a major financial institution, filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Travere Therapeutics, Inc. common s -
BlackRock Amends Travere Therapeutics Stake (SC 13G/A)
— Jan 24, 2024
BlackRock Inc. filed an amended SC 13G/A on January 24, 2024, indicating its ownership of Travere Therapeutics, Inc. common stock as of December 31, 2023. This
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX